Consulting Capabilities

Whether your product is in early stage development, is close to launch or launching in a different indication, our pharma experience and expertise will support critical thinking around market access.

Pricing Strategies
  • For all stages of the product life-cycle
  • Strategies for launch, Loss of Exclusivity and indication sequencing
  • Price sensitivity and price optimisation
TPP Assessment (Payer and KOL)
  • Identify evidence gaps
  • Develop minimum reimbursable profiles
  • Market Access input into development plans
  • Health Technology Assessment insights
Revenue Optimisation and Contracting
  • Customised Excel models for revenue optimisation and contracting
  • Training for roll-out to LoCs 
Qualitative Payer Research
  • Access to personally managed network of over 2,000 payers and KOLs in key national, regional and local roles for targeted questioning and quick turnaround
Advisory Boards
  • Gaining expert knowledge throughout the process, from logistics, briefings and content development to moderation
Due Diligence
  • Fast turn-around Commercial and Market Access Due Diligence projects
Our Strengths

Strong personally managed Payer and KOL network in 40+ countries

Payers and payer adviser respondents are either currently involved or have completed their assignment recently

Interviews conducted only by Access Infinity consultants to prevent diluted insights

Directors held senior global positions in pharma companies and understand the dynamics of internal and external stakeholder management

London Head Office

Labs Atrium

The Stables Market



Founding Director
  • LinkedIn - White Circle
  • Twitter - White Circle
  • Instagram - White Circle

Legal Policies